Cargando…

Precision Vaccine Adjuvants for Older Adults: A Scoping Review( )

Older adults, defined as those ≥60 years of age, are a growing population vulnerable to infections including severe acute respiratory syndrome coronavirus 2. Although immunization is a key to protecting this population, immunosenescence can impair responses to vaccines. Adjuvants can increase the im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nanishi, Etsuro, Angelidou, Asimenia, Rotman, Chloe, Dowling, David J, Levy, Ofer, Ozonoff, Al
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Precision Vaccines Supplement
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376277/ https://www.ncbi.nlm.nih.gov/pubmed/35439286 http://dx.doi.org/10.1093/cid/ciac302

Ejemplares similares

Precision Vaccines: Lessons Learned From the Coronavirus Pandemic( )
por: Angelidou, Asimenia, et al.
Publicado: (2022)

A Precision Adjuvant Approach to Enhance Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines Optimized for Immunologically Distinct Vulnerable Populations( )
por: Dowling, David J, et al.
Publicado: (2022)

Implications of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic on the Epidemiology of Pediatric Respiratory Syncytial Virus Infection( )
por: Odumade, Oludare A, et al.
Publicado: (2022)

Acceptability of a Fentanyl Vaccine to Prevent Opioid Overdose and Need for Personalized Decision-Making( )
por: Weitzman, Elissa R, et al.
Publicado: (2022)

Advancing the Science of Vaccine Safety During the Coronavirus Disease 2019 (COVID-19) Pandemic and Beyond: Launching an International Network of Special Immunization Services( )
por: Top, Karina A, et al.
Publicado: (2022)

Perinatally Human Immunodeficiency Virus–Infected Adolescents and Young Adults Demonstrate Distinct BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Immunogenicity( )
por: Morrocchi, Elena, et al.
Publicado: (2022)

Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines: Perceptions and Attitudes From the Food and Drug Administration Public Commentary( )
por: Weitzman, Elissa R, et al.
Publicado: (2022)

Competing Responses to Global Inequalities in Access to COVID Vaccines: Vaccine Diplomacy and Vaccine Charity Versus Vaccine Liberty
por: Sparke, Matthew, et al.
Publicado: (2022)

Why We Need Precision Vaccinology( )
por: Plotkin, Stanley A
Publicado: (2022)

Association of Frailty, Age, and Biological Sex With Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccine–Induced Immunity in Older Adults( )
por: Shapiro, Janna R, et al.
Publicado: (2022)

Advancing Precision Vaccinology by Molecular and Genomic Surveillance of Severe Acute Respiratory Syndrome Coronavirus 2 in Germany, 2021( )
por: Oh, Djin Ye, et al.
Publicado: (2022)

Toward precision adjuvants: optimizing science and safety
por: Nanishi, Etsuro, et al.
Publicado: (2020)

Precision Vaccinology Approaches for the Development of Adjuvanted Vaccines Targeted to Distinct Vulnerable Populations
por: Lee, Branden, et al.
Publicado: (2023)

Waning effectiveness of SARS-CoV-2 mRNA vaccines in older adults: a rapid review
por: Nanishi, Etsuro, et al.
Publicado: (2022)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Africa: Current Considerations and Future Projections( )
por: Idoko, Olubukola T, et al.
Publicado: (2022)

Bell's palsy and SARS-CoV-2 vaccines
por: Ozonoff, Al, et al.
Publicado: (2021)

Bell's palsy and SARS-CoV-2 vaccines—an unfolding story – Authors' reply
por: Ozonoff, Al, et al.
Publicado: (2021)

Dose Selection for an Adjuvanted Respiratory Syncytial Virus F Protein Vaccine for Older Adults Based on Humoral and Cellular Immune Responses
por: Falloon, Judith, et al.
Publicado: (2017)

BCG as a Case Study for Precision Vaccine Development: Lessons From Vaccine Heterogeneity, Trained Immunity, and Immune Ontogeny
por: Angelidou, Asimenia, et al.
Publicado: (2020)

Precision Vaccine Development: Cues From Natural Immunity
por: Barman, Soumik, et al.
Publicado: (2022)

The Carbomer-Lecithin Adjuvant Adjuplex Has Potent Immunoactivating Properties and Elicits Protective Adaptive Immunity against Influenza Virus Challenge in Mice
por: Wegmann, Frank, et al.
Publicado: (2015)

Clinical Trial of an Oral Live Shigella sonnei Vaccine Candidate, WRSS1, in Thai Adults
por: Pitisuttithum, Punnee, et al.
Publicado: (2016)

Vaccine attributes and vaccine uptake in Hungary: evidence from a conjoint experiment
por: Thompson, Jack, et al.
Publicado: (2023)

Integrative Metabolomics to Identify Molecular Signatures of Responses to Vaccines and Infections
por: Diray-Arce, Joann, et al.
Publicado: (2020)

Characterization and Vaccine Potential of Membrane Vesicles Produced by Francisella noatunensis subsp. orientalis in an Adult Zebrafish Model
por: Lagos, Leidy, et al.
Publicado: (2017)

The politics of vaccine hesitancy in Europe
por: Stoeckel, Florian, et al.
Publicado: (2022)

COVID-19 vaccination and changes in preventive behaviours: findings from the 2021 vaccine roll-out in Switzerland
por: Hitchman, Sara C, et al.
Publicado: (2023)

Attitudes towards COVID-19 vaccination and intention to get vaccinated in Western Balkans: cross-sectional survey
por: Jeremic Stojkovic, Vida, et al.
Publicado: (2023)

Consumption and tax gains attributable to Covid-19 vaccinations in 12 EU countries with low vaccination rates
por: Cylus, Jonathan, et al.
Publicado: (2023)

The far-right and anti-vaccine attitudes: lessons from Spain’s mass COVID-19 vaccine roll-out
por: Serrano-Alarcón, Manuel, et al.
Publicado: (2023)

Adjuvant Discovery via a High Throughput Screen using Human Primary Mononuclear Cells
por: Chew, Katherine, et al.
Publicado: (2022)

Public health impact of herpes zoster vaccination on older adults in Hong Kong
por: Chan, Paul K. S., et al.
Publicado: (2023)

Subtype C gp140 Vaccine Boosts Immune Responses Primed by the South African AIDS Vaccine Initiative DNA-C2 and MVA-C HIV Vaccines after More than a 2-Year Gap
por: Gray, Glenda E., et al.
Publicado: (2016)

Explaining the gender gap in COVID-19 vaccination attitudes
por: Toshkov, Dimiter
Publicado: (2023)

Germinal Center B Cell and T Follicular Helper Cell Responses to Viral Vector and Protein-in-Adjuvant Vaccines
por: Wang, Chuan, et al.
Publicado: (2016)

Antibody Persistence in Young Children 5 Years after Vaccination with a Combined Haemophilus influenzae Type b-Neisseria meningitidis Serogroup C Conjugate Vaccine Coadministered with Diphtheria-Tetanus-Acellular Pertussis-Based and Pneumococcal Conjugate Vaccines
por: Tejedor, Juan Carlos, et al.
Publicado: (2016)

Attenuation of Replication-Competent Adenovirus Serotype 26 Vaccines by Vectorization
por: Maxfield, Lori F., et al.
Publicado: (2015)

Vaccination barriers and drivers in Romania: a focused ethnographic study
por: Dube, Eve, et al.
Publicado: (2022)

Comparative Efficacy of Feline Leukemia Virus (FeLV) Inactivated Whole-Virus Vaccine and Canarypox Virus-Vectored Vaccine during Virulent FeLV Challenge and Immunosuppression
por: Patel, M., et al.
Publicado: (2015)

Measles outbreak in Romania: understanding factors related to suboptimal vaccination uptake
por: Habersaat, Katrine Bach, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cjag44cm20kd8fvp4b4cbv8e0f